- Home
- BGSF vs CASI Comparison
BGSF vs CASI Comparison
Compare BGSF & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGSF
- CASI
- Stock Information
- Founded
- BGSF 2007
- CASI 1991
- Country
- BGSF United States
- CASI China
- Employees
- BGSF N/A
- CASI N/A
- Industry
- BGSF Professional Services
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- BGSF Consumer Discretionary
- CASI Health Care
- Exchange
- BGSF Nasdaq
- CASI Nasdaq
- Market Cap
- BGSF 66.0M
- CASI 58.8M
- IPO Year
- BGSF N/A
- CASI 1996
- Fundamental
- Price
- BGSF $4.97
- CASI $2.45
- Analyst Decision
- BGSF
- CASI Strong Buy
- Analyst Count
- BGSF 0
- CASI 1
- Target Price
- BGSF N/A
- CASI $6.00
- AVG Volume (30 Days)
- BGSF 11.0K
- CASI 14.6K
- Earning Date
- BGSF 03-12-2025
- CASI 03-27-2025
- Dividend Yield
- BGSF N/A
- CASI N/A
- EPS Growth
- BGSF N/A
- CASI N/A
- EPS
- BGSF N/A
- CASI N/A
- Revenue
- BGSF $281,656,000.00
- CASI $22,055,000.00
- Revenue This Year
- BGSF N/A
- CASI N/A
- Revenue Next Year
- BGSF $5.63
- CASI $134.79
- P/E Ratio
- BGSF N/A
- CASI N/A
- Revenue Growth
- BGSF N/A
- CASI N/A
- 52 Week Low
- BGSF $4.70
- CASI $2.05
- 52 Week High
- BGSF $10.50
- CASI $7.67
- Technical
- Relative Strength Index (RSI)
- BGSF 39.14
- CASI 42.71
- Support Level
- BGSF $4.90
- CASI $2.48
- Resistance Level
- BGSF $5.19
- CASI $2.65
- Average True Range (ATR)
- BGSF 0.19
- CASI 0.17
- MACD
- BGSF 0.01
- CASI 0.03
- Stochastic Oscillator
- BGSF 40.30
- CASI 39.47
About BGSF BGSF Inc.
BGSF Inc is a provider of workforce solutions operating primarily in the U.S. across two segments: Property Management and Professional. In the Property Management segment, BGSF offers office and maintenance talent to clients, facilitating their staffing needs with short-term and consulting solutions. The Professional segment specializes in IT, offering skilled professionals in SAP, Workday, and other areas to Fortune 500 companies and consulting firms nationwide. BGSF's workforce services include on-demand assignments, consulting, and managed solutions, allowing clients to flexibly manage their workforce needs. With a focus on converting fixed personnel costs to variable expenses, BGSF enables companies to effectively address fluctuations in demand while optimizing costs.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.